Investment Q&A

Q: Please comment on whether to buy or sell these companies. GGD has cash flows of $2.8M in Q1. Is it good buy at these levels.

Q: Hi Guys,

Care to comment on Knight Therapeutics increased position today in PDP? Is PDP still quite risky and would you recommend it with the potential approval of 2 of its drugs this year?

Q: What are your comments on Knight acquiring a minor stake in Pediapharm today? Is it a good time to buy PDP? Thank you for a great service. Cole

Q: Given your endorsement of J. Goodman's ability and based on my research to confirm same, for high risk speculative plays I have essentially copied Goodman by taking positions in CRH earlier this year and PDP recently and before its increase. Like Goodman I took profits on CRH - as it turns out a little early but still a very healthy (no pun) return. For PDP I now have significant paper gains. I appreciate Goodman is principally lending to these smaller companies and I find GUD's strategy in this regard intriguing. Are you aware of other pharma companies that GUD has also financed or plans to finance? I will likely take gains on PDP but I would appreciate any insight you could offer on the recent spike and significant increase in volume. I only have a small position in this one, even after the spike, and I don't need the money. It goes without saying that your independent informed view is greatly valued. Thanks!!!

Q: Is PDP the next CRH?

Q: Please comment on US etf PDP,DWAS and DLS. Thanks